跳至主要内容
临床试验/CTRI/2012/08/002939
CTRI/2012/08/002939招募中未知

Validation of EORTC CIPN20 module into Indian languages Hindi and Marathi for assessing Quality of Lifein chemotherapy induced peripheral neuropathy

Tata Memorial Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Either of the following
  • a.Patients of breast cancer who have recently completed or are undergoing adjuvant chemotherapy using an anthracycline-taxane regimen.
  • b.Patients of epithelial ovarian cancer who have recently completed or are undergoing first-line taxane-platinum chemotherapy in the neoadjuvant or adjuvant setting.
  • c.Patients of head and neck cancer who are undergoing first-line platinum and/or taxane based chemotherapy or have recently completed it.
  • 2)Completed chemotherapy within 12 weeks of inclusion in the study
  • 3)Patients with evidence of clinical neuropathy as judged by the treating physicians.
  • 4)Literate patients who can read the translated questionnaires.
  • 5)Age more than 18 years
  • 6)Patients willing to participate in the Study.

排除标准

  • Patients unable to complete the questionnaire

研究者

相似试验

Validation of EORTC CIPN20 module in Indian... | 临床试验